- Cemiplimab2021 | First Faculty of Medicine
- Cemiplimab as a hope for a young patient with aggressive squamous cell carcinoma of the sacrococcygeal region2021 | Faculty of Medicine in Pilsen
- Cemiplimab: monotherapy and combination therapy of NSCLC - analysis of locally advanced disease2023 | First Faculty of Medicine
- Cemiplimab in patients with metastatic of locally advanced cutaneous squamous-cell carcinoma2020 | Faculty of Medicine in Hradec Králové
- Cemiplimab in the treatment of NSCLC: EMPOWER-Lung 1 trial2021 | First Faculty of Medicine
- Cemiplimab2020 | Third Faculty of Medicine
- Nemelanomové kožní nádory - cemiplimab v léčbě pokročilého a metastazujícího kožního skvamózního karcinomu2021 | First Faculty of Medicine
- Immunotherapy for lung cancer at the ESMO virtual congress2020 | Publication without faculty affiliation
- Immunotherapy in non-melanoma skin cancer +12022 | First Faculty of Medicine
- Real-accesible novelties in immunotherapy from the perspective of a medical oncologist working in the Czech Republic2020 | Faculty of Medicine in Hradec Králové
- Treatment of spinalioma in clinical practice2022 | First Faculty of Medicine
- Virtual WCLC 2020 and Immunotherapy - Conference Report2021 | Publication without faculty affiliation
- Immunotherapy in the first line treatment of non-small cell lung cancer2021 | Publication without faculty affiliation
- Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches2021 | Faculty of Medicine in Pilsen
- European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 20232023 | Third Faculty of Medicine
- European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 20232023 | Third Faculty of Medicine
